Cargando…

Severe epistaxis related to intravitreal bevacizumab

Detalles Bibliográficos
Autores principales:	Otten, Leila S., Butterhoff‐Terlingen, Madelon H., Mulder, Verena C., Lagas‐ de Graaf, Willemien, van der Hage‐Lie, Angela M., van der Linden, Paul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004067/ https://www.ncbi.nlm.nih.gov/pubmed/31233274 http://dx.doi.org/10.1111/aos.14176

Ejemplares similares

Intravitreal bevacizumab
por: Khamar, Bakulesh M
Publicado: (2018)

The effect of the anticholinergic burden on duration and severity of delirium in older hip‐surgery patients with and without haloperidol prophylaxis: A post hoc analysis
por: Tillemans, Monique P. H., et al.
Publicado: (2021)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
por: Joob, Beuy, et al.
Publicado: (2017)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

Paralytic ileus after bilateral intravitreal injection of bevacizumab
por: Kim, Young Gyun, et al.
Publicado: (2016)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Assessment of drug-related problems at the emergency department in older patients living with frailty: pharmacist-led medication reviews within a geriatric care team
por: van Nuland, Merel, et al.
Publicado: (2023)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

The Endovascular Treatment of Epistaxis
por: Nicolay, S., et al.
Publicado: (2015)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Intravitreal bevacizumab: an analysis of the evidence
por: Smit, Derrick P, et al.
Publicado: (2007)

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
por: Thompson, Andrew B., et al.
Publicado: (2014)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016)

Decompression retinopathy after intravitreal bevacizumab and anterior chamber paracentesis in a patient with neovascular glaucoma
por: Kim, Eung Suk, et al.
Publicado: (2016)

Comment on: An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
por: Kalamkar, Charudutt, et al.
Publicado: (2016)

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Response of Diabetic Papillopathy to Intravitreal Bevacizumab
por: Al-Dhibi, Hassan, et al.
Publicado: (2011)

Erectile Dysfunction Following Intravitreal Bevacizumab
por: Yohendran, Jayshan, et al.
Publicado: (2010)

Intravitreal administration of bevacizumab: pros and cons
por: Dashti-Khavidaki, Simin, et al.
Publicado: (2015)

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
por: Lemos-Reis, Ricardo, et al.
Publicado: (2014)

Epistaxis
por: Díaz Reyes, Abigail
Publicado: (2010)

Epistaxis
Publicado: (1909)

Epistaxis
por: Barton, B. W.
Publicado: (1878)

Epistaxis
por: de Mello, João Ferreira
Publicado: (2015)

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
por: Avery, Robert L., et al.
Publicado: (2017)

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Singh, Sunil Kumar, et al.
Publicado: (2014)

Piperacillin/tazobactem induced epistaxis- A case report
por: Tomar, Gaurav Singh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sb2759fil46lc19v40qc8v4bdd